Capacity to manufacture under Canada's Access to Medicines Regime (English, HTML)

View metadata and access the original English HTML file: Capacity to manufacture under Canada's Access to Medicines Regime.

Format

HTML

Access

file-only

Publisher-reported update

2020-09-17

To participate in the Regime, an eligible importing country must declare that it has insufficient or no pharmaceutical manufacturing capacity in relation to the specific product it is requesting. It is up to each country to determine for itself the level of its manufacturing capacity.

Access original file